“…When platelets become drug carriers, due to their low dynamics, there will be some shortcomings, such as low binding efficiency, slow transport speed, limited therapeutic effect, and so on. Nanomotors can convert energy into propulsive force, which makes them a viable route for drugs delivery. , In addition, nanomotors accelerate self-drive in response to specific triggers, such as light, chemicals fuels, heat, and magnetic fields. − However, such systems may experience limitations because of the requirement for complex actuation equipment and are significantly different from the biological environment. , Therefore, the use of enzymes to modify nanomotors is a practical approach, as they can transform substrate biofuels into the driving forces. − These enzyme-powered nanomotors can produce sufficient power to overcome the random Brownian motion when used in biological media containing biofuels. , In particular, enzymatic modification of nanomotors in a Janus-mediated manner has been demonstrated to be feasible for various applications. Generating an efficient directional propulsion system and obtaining an asymmetric driving force is vital.…”